Handelsavisen
prelaunch
NA
NATR.PSX PSX (Pakistan) Diversified Food Producers

Natr.Psx

$379,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-2,5 %
ROE
-29,5 %
Net margin
-4,8 %
Debt / equity
1,21
Beta
52w range
Volume
357
Day range
$21,47–$22,02
Prev close
$21,86
Open
$21,88
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

NATR.PSX is an energy company engaged in oil and gas refining and marketing, generating revenue primarily through the production and sale of refined petroleum products.

Business. Nature's Sunshine Products Inc (NATR.O) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

Classification99 %
SectorConsumer Staples
Industry groupDiversified Food Producers
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target33,00

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
33,00
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
American Century Investment Management, Inc.
largest disclosed fund holder
Profitability
-29,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NATR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NATR.PSX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Nature's Sunshine Products Inc (NATR.O) has recorded a notable addition to its shareholder base, marking the first analysis for this ticker. As of March 31, 2026, investor ID 931 acquired a position of 516 shares, valued at approximately $12,270. This transaction represents a weight of roughly 0.0000059% of the company's equity, detected on June 20, 2026. This holder change is the primary material signal for the company, as there are no prior basis points for delta computation in recent material changes. The acquisition by investor ID 931 stands out as a distinct event in an otherwise static landscape of reported changes for the period. The significance of this move is contextualized by the company's current market profile. Nature's Sunshine Products Inc currently has zero analyst coverage and zero index memberships, indicating limited institutional scrutiny or inclusion in major benchmarks. The company also reports zero officers in the current dataset, highlighting a sparse public profile regarding executive leadership visibility. Despite the lack of analyst or index presence, the company maintains a base of 25 top holders. The entry of investor ID 931 adds to this existing holder structure, suggesting continued, albeit small-scale, interest from specific investors. This activity provides a baseline for future monitoring of shareholder composition in the absence of broader market signals.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Nature's Sunshine Products Inc (NATR.O) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

    Classification99 %
    SectorConsumer Staples
    Industry groupDiversified Food Producers
    AI synthesis
    GENERATED

    NATR.PSX's capital structure is characterized by a debt-to-equity ratio of 1.21, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.75, suggesting that it may struggle to meet short-term obligations without additional financing. The company's free cash flow is negative at -$13.06 billion, and operating cash flow is also negative at -$6.21 billion, signaling significant cash outflows from operations.

    Profitability metrics for NATR.PSX are sharply negative, with a return on equity of -29.55% and a return on assets of -9.94%. These figures are well below the industry norms for oil and gas refining and marketing, which typically exhibit positive returns in stable market conditions. The company's net income is -$14.87 billion, and operating income is -$7.70 billion, reflecting a challenging operating environment.

    The company's revenue is concentrated in a single business segment, oil and gas refining and marketing, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's total revenue is $30.77 billion, but the absence of segment-specific revenue data limits the ability to assess performance across different product lines or regions.

    NATR.PSX's growth trajectory is constrained by its current financial performance. The company's operating cash flow and free cash flow are both negative, and there is no disclosed revenue growth in the most recent financial period. The outlook for the current fiscal year is uncertain, with no clear indicators of improvement in profitability or cash flow generation.

    The company's risk profile is elevated due to its negative net cash position after subtracting total debt. The liquidity risk is moderate, but the company's ability to service its $60.88 billion in long-term debt is questionable given its negative operating cash flow. The dilution risk is currently low, but the company's capital structure and financial performance could change this if additional financing is required.

    Recent events, including the latest financial filings, indicate a challenging operating environment for NATR.PSX. The company's financial statements show a significant decline in profitability and liquidity, which may be attributed to industry-wide headwinds such as fluctuating oil prices and increased regulatory scrutiny. No recent transcripts or press releases provide additional context on the company's strategic direction or operational improvements.

    Nature's Sunshine Products Inc (NATR.O) has recorded a notable addition to its shareholder base, marking the first analysis for this ticker. As of March 31, 2026, investor ID 931 acquired a position of 516 shares, valued at approximately $12,270. This transaction represents a weight of roughly 0.0000059% of the company's equity, detected on June 20, 2026. This holder change is the primary material signal for the company, as there are no prior basis points for delta computation in recent material changes. The acquisition by investor ID 931 stands out as a distinct event in an otherwise static landscape of reported changes for the period. The significance of this move is contextualized by the company's current market profile. Nature's Sunshine Products Inc currently has zero analyst coverage and zero index memberships, indicating limited institutional scrutiny or inclusion in major benchmarks. The company also reports zero officers in the current dataset, highlighting a sparse public profile regarding executive leadership visibility. Despite the lack of analyst or index presence, the company maintains a base of 25 top holders. The entry of investor ID 931 adds to this existing holder structure, suggesting continued, albeit small-scale, interest from specific investors. This activity provides a baseline for future monitoring of shareholder composition in the absence of broader market signals.

    Key takeaways
    • NATR.PSX is experiencing significant financial distress, with negative net income and operating income.
    • The company's liquidity position is weak, with a current ratio below 1 and negative free cash flow.
    • Profitability metrics are sharply negative, indicating a challenging operating environment.
    • The company's revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
    • The company's debt load is substantial, with a debt-to-equity ratio of 1.21, raising concerns about its ability to service debt obligations.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $379,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $50.32B
    Net cash
    -$60.88B
    Current ratio
    0.8
    Debt / equity
    1.2
    ROA
    -9.9%
    ROE
    -29.5%
    Cash conversion
    42.0%
    CapEx / revenue
    -0.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    General health40,0 %
    disclosed · sec_xbrl · 2025-12-31
    Digestive25,9 %
    disclosed · sec_xbrl · 2025-12-31
    Personal care4,8 %
    disclosed · sec_xbrl · 2025-12-31
    Weight management3,7 %
    disclosed · sec_xbrl · 2025-12-31

    Market share

    INDUSTRYSEGMENTCOMPANYConsumer Non-CyclicalsIndustryDiversified Food Producers468,7B node revenueJBS 18,4%TSN 11,6%MDLZ 8,2%ADM 5,3%KHC 5,3%BIP 4,9%GIS 4,2%PPC 4,0%Other 38,1%
    Source: company disclosures · own-taxonomy revenue-covered setNATR 0,1% · rank #32 of 65

    Business relationships

    Business relationships46 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries46
    EX21:11bc8c1e2d32EX21:11bc8c1e2d32Subsidiarie97%
    EX21:13035f8d14bcEX21:13035f8d14bcSubsidiarie97%
    EX21:152f429c967dEX21:152f429c967dSubsidiarie97%
    EX21:1792642b1c3eEX21:1792642b1c3eSubsidiarie97%
    EX21:1aae9ebb1fb9EX21:1aae9ebb1fb9Subsidiarie97%
    EX21:20d1a56d4a69EX21:20d1a56d4a69Subsidiarie97%
    EX21:23a8bf172cc8EX21:23a8bf172cc8Subsidiarie97%
    EX21:2e3686dbf57fEX21:2e3686dbf57fSubsidiarie97%
    EX21:2f5e5f1097b8EX21:2f5e5f1097b8Subsidiarie97%
    EX21:30d05e9df6ebEX21:30d05e9df6ebSubsidiarie97%
    EX21:37c453c52e6aEX21:37c453c52e6aSubsidiarie97%
    EX21:3fdf92b75aa7EX21:3fdf92b75aa7Subsidiarie97%
    EX21:43706750a98fEX21:43706750a98fSubsidiarie97%
    EX21:4d2ee3cd8585EX21:4d2ee3cd8585Subsidiarie97%
    EX21:4ecdd4bb1bbeEX21:4ecdd4bb1bbeSubsidiarie97%
    EX21:53d5a52587c2EX21:53d5a52587c2Subsidiarie97%
    EX21:54fd55f518b5EX21:54fd55f518b5Subsidiarie97%
    EX21:58c20fd6e480EX21:58c20fd6e480Subsidiarie97%
    EX21:628e7337bcabEX21:628e7337bcabSubsidiarie97%
    EX21:6c883b783dc5EX21:6c883b783dc5Subsidiarie97%
    EX21:74df1ee48843EX21:74df1ee48843Subsidiarie97%
    EX21:7de54246e978EX21:7de54246e978Subsidiarie97%
    EX21:81d7e1de5e9fEX21:81d7e1de5e9fSubsidiarie97%
    EX21:862c0cc5e641EX21:862c0cc5e641Subsidiarie97%
    EX21:8da6d98aaa76EX21:8da6d98aaa76Subsidiarie97%
    EX21:989dd09b0d62EX21:989dd09b0d62Subsidiarie97%
    EX21:9a7ec18476cdEX21:9a7ec18476cdSubsidiarie97%
    EX21:9fd680947228EX21:9fd680947228Subsidiarie97%
    EX21:a153af9df2dfEX21:a153af9df2dfSubsidiarie97%
    EX21:a76f298ad210EX21:a76f298ad210Subsidiarie97%
    EX21:a86c3d0a7a3fEX21:a86c3d0a7a3fSubsidiarie97%
    EX21:aa11f95dd51fEX21:aa11f95dd51fSubsidiarie97%
    EX21:aeb065177cf8EX21:aeb065177cf8Subsidiarie97%
    EX21:b51bb425f931EX21:b51bb425f931Subsidiarie97%
    EX21:b904a10d007dEX21:b904a10d007dSubsidiarie97%
    EX21:bc4918ed9470EX21:bc4918ed9470Subsidiarie97%
    EX21:bf5e6c8b778cEX21:bf5e6c8b778cSubsidiarie97%
    EX21:c90737af857bEX21:c90737af857bSubsidiarie97%
    EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
    EX21:da6c71f8f243EX21:da6c71f8f243Subsidiarie97%
    EX21:e402430e72e4EX21:e402430e72e4Subsidiarie97%
    EX21:e91cdc3da34bEX21:e91cdc3da34bSubsidiarie97%
    EX21:f0bcecb4b88fEX21:f0bcecb4b88fSubsidiarie97%
    EX21:f217265321d5EX21:f217265321d5Subsidiarie97%
    EX21:f3929ba031bdEX21:f3929ba031bdSubsidiarie97%
    EX21:fa8fc7a64324EX21:fa8fc7a64324Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs NATR · multiples and returns
    JB
    JBS
    JBS
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    TS
    TSN
    Tyson Foods Inc
    $59,61
    21,1B USD
    P/E
    45,3x
    +25,6 vs self
    Div yield
    vs self
    ROE
    2,6 %
    -9,5 vs self
    MD
    MDLZ
    MONDELEZ INTERNATIONAL, INC.
    $61,73
    80,1B USD
    P/E
    28,9x
    +9,3 vs self
    Div yield
    3,3 %
    vs self
    ROE
    10,1 %
    -2,0 vs self
    AD
    ADM
    Archer-daniels-midland Co
    $78,06
    37,8B USD
    P/E
    36,8x
    +17,1 vs self
    Div yield
    2,5 %
    vs self
    ROE
    4,7 %
    -7,4 vs self
    KH
    KHC
    THE KRAFT HEINZ COMPANY
    $26,44
    31,3B USD
    P/E
    vs self
    Div yield
    6,5 %
    vs self
    ROE
    -13,8 %
    -25,9 vs self
    BI
    BIP
    BIP.WA
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    GI
    GIS
    General Mills Inc
    $36,08
    19,4B USD
    P/E
    vs self
    Div yield
    6,6 %
    vs self
    ROE
    -1,2 %
    -13,3 vs self
    PP
    PPC
    PILGRIM'S PRIDE LTD.
    $27,92
    6,6B USD
    P/E
    6,4x
    -13,3 vs self
    Div yield
    vs self
    ROE
    29,4 %
    +17,3 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Segment revenue · next quarter
    No quarterly segment estimate
    Segment data is reported at full-fiscal-year granularity only — no quarterly segment split is forecast (a quarterly figure is never inferred from the annual). See the full-fiscal-year segment-revenue card below.
    Full fiscal year~1 year ahead
    Segment-revenue forecast · full fiscal year · native currency
    • General healthFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-12-31 · conf —202,5MFORECAST
    • DigestiveFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-12-31 · conf —131,1MFORECAST
    • (unclassified — pending L6)FY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-12-31 · conf —43,0MFORECAST
    • Personal careFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-12-31 · conf —24,5MFORECAST
    • Weight managementFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-12-31 · conf —18,9MFORECAST
    • General healthFY2025 — reported · conf —193,8MREPORTED
    • DigestiveFY2025 — reported · conf —117,8MREPORTED
    • (unclassified — pending L6)FY2025 — reported · conf —40,8MREPORTED
    • Weight managementFY2025 — reported · conf —21,6MREPORTED
    • Personal careFY2025 — reported · conf —18,8MREPORTED
    Model estimate of reported / forward segment revenue in issuer-native currency. Confidence shown where the model calibrated it; "—" where not (never inferred).
    Probabilistic model output — not investment advice. · generated 2026-06-29

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$33,00
    Mean$33,00
    Median$33,00
    High$33,00
    Spot$379,50
    −91.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-2,5 %Below median
    Net Margin-4,8 %Below median
    ROE-29,5 %Bottom quartile
    Capex / Rev-0,5 %Above median
    D/E1,21Bottom quartile
    Cash Conv0,42Below median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    5 %
    Base rate
    3 %
    Band
    Moderate
    180-day horizon · target 2027-01-16 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • NATR.PSX Market data — financials · 2026-05-28

    Ownership & reference

    Top holders

    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$14M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$21M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$4M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$3M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$3M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$9M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$6M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$12M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$8M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$17M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$2M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$1M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$1M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 5 sellsnet -$742K16 insiders · last 365d
    • Herbert Kevin R.EVP & President, North America · Common SharesOther 1 976 @ $21,02$42K · 2026-06-26
    • Herbert Kevin R.EVP & President, North America · Common SharesSold 1 134 @ $20,63$23K · 2026-06-12
    • Herbert Kevin R.EVP & President, North America · Common SharesSold 866 @ $20,75$18K · 2026-06-12
    • Yates Bryant JEVP & President, Europe · Common SharesSold 11 968 @ $19,90$238K · 2026-06-05
    • Norman Daniel CEVP & President, Asia · Common SharesSold 9 713 @ $20,64$200K · 2026-06-01
    • Brower Nathan GEVP, General Counsel · Common SharesSold 12 015 @ $21,84$262K · 2026-05-21
    • Fasching Steven J.Director · Common SharesOther 4 500 · 2026-05-15
    • Wissmiller HeidiDirector · Common SharesOther 4 500 · 2026-05-15
    • Yates Bryant JEVP & President, Europe · Common SharesOther 8 753 · 2026-05-15
    • Brower Nathan GEVP, General Counsel · Common SharesOther 9 001 · 2026-05-15
    • May KatieDirector · Common SharesOther 4 500 · 2026-05-15
    • Fritz Erich AEVP, Global Supply Chain · Common SharesOther 9 226 · 2026-05-15
    • Romanzi Kenneth G.Director, Chief Executive Officer · Common SharesOther 33 753 · 2026-05-15
    • Fuller Kevin GregoryGlobal Chief Marketing Officer · Common SharesOther 8 984 · 2026-05-15
    • Lanoy Jonathan DavidSVP, Chief Accounting Officer · Common SharesOther 6 107 · 2026-05-15
    • Norman Daniel CEVP & President, Asia · Common SharesOther 11 377 · 2026-05-15
    • Herbert Kevin R.EVP & President, North America · Common SharesOther 8 326 · 2026-05-15
    • Straus Robert DDirector · Common SharesOther 4 500 · 2026-05-15
    • Yang RongDirector · Common SharesOther 4 500 · 2026-05-15
    • Kopf CurtisDirector · Common SharesOther 4 500 · 2026-05-15
    • Roering TessDirector · Common SharesOther 4 500 · 2026-05-15
    • Brower Nathan GEVP, General Counsel · Common SharesOther 2 014 · 2026-05-05
    • Brower Nathan GEVP, General Counsel · Common SharesOther 582 @ $25,91$15K · 2026-05-05
    • Brower Nathan GEVP, General Counsel · Common SharesOther 2 235 · 2026-05-05
    • Brower Nathan GEVP, General Counsel · Common SharesOther 645 @ $25,91$17K · 2026-05-05

    Short positioning

    505.7Kshares short-19.2% vs prior
    5.08days to cover
    68.1%short of daily vol
    99fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NATR.PSXCanonical
    PSX (Pakistan) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    NATREX21:11bEX21:130EX21:152EX21:179EX21:1aaEX21:20dEX21:23aEX21:2e3EX21:2f5EX21:30dDiversified Fo
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 7.1%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 10.9%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 39.6%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 2.1%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 24.7%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 8.4%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 5.7%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 11.8%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 153.7%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 165.0%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 163.4%Derived (calculated)
    • Net margin (FY 2025-12-31): 4.1%Derived (calculated)
    • Gross margin (FY 2025-12-31): 72.4%Derived (calculated)
    • Return on assets (FY 2025-12-31): 7.5%Derived (calculated)
    • Current ratio (FY 2025-12-31): 2.28xDerived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 23.1%Derived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -40.9%Derived (calculated)
    • Current assets (annual): USD 178.84MSEC XBRL filing
    • Capex (annual): USD 6.48MSEC XBRL filing
    • Current liabilities (annual): USD 78.54MSEC XBRL filing
    • Shares outstanding (annual): 17.51MSEC XBRL filing
    • Cash & equivalents (annual): USD 93.89MSEC XBRL filing
    • Total liabilities (annual): USD 99.59MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 1SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: insider_flow_signal (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-26 00:00 UTCINSIDER5 insider transactions — 2026-06 · net sell $522k
    2026-06-26 00:00 UTCINSIDER5 insider transactions — 2026-06 · net sell $522k
    2026-06-26 00:00 UTCINSIDER5 insider transactions — 2026-06 · net sell $522k
    2026-06-26INSIDERHerbert Kevin R. transacted 2.0k sh Common Shares — EVP & President, North America ~$42k
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged
    2026-06-12INSIDERHerbert Kevin R. sold 1.1k sh Common Shares — EVP & President, North America ~$23k
    2026-06-12INSIDERHerbert Kevin R. sold 866 sh Common Shares — EVP & President, North America ~$18k
    2026-06-05INSIDERYates Bryant J sold 12.0k sh Common Shares — EVP & President, Europe ~$238k
    2026-06-01INSIDERNorman Daniel C sold 9.7k sh Common Shares — EVP & President, Asia ~$200k
    2026-05-21 00:00 UTCINSIDER38 insider transactions — 2026-05 · net sell $440k
    2026-05-21 00:00 UTCINSIDER38 insider transactions — 2026-05 · net sell $440k
    2026-05-21 00:00 UTCINSIDER38 insider transactions — 2026-05 · net sell $440k
    2026-05-21INSIDERBrower Nathan G sold 12.0k sh Common Shares — EVP, General Counsel ~$262k
    2026-05-15INSIDERFasching Steven J. transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERWissmiller Heidi transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERYates Bryant J transacted 8.8k sh Common Shares — EVP & President, Europe
    2026-05-15INSIDERBrower Nathan G transacted 9.0k sh Common Shares — EVP, General Counsel
    2026-05-15INSIDERMay Katie transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERFritz Erich A transacted 9.2k sh Common Shares — EVP, Global Supply Chain
    2026-05-15INSIDERRomanzi Kenneth G. transacted 33.8k sh Common Shares — Director, Chief Executive Officer
    2026-05-15INSIDERFuller Kevin Gregory transacted 9.0k sh Common Shares — Global Chief Marketing Officer
    2026-05-15INSIDERLanoy Jonathan David transacted 6.1k sh Common Shares — SVP, Chief Accounting Officer
    2026-05-15INSIDERNorman Daniel C transacted 11.4k sh Common Shares — EVP & President, Asia
    2026-05-15INSIDERHerbert Kevin R. transacted 8.3k sh Common Shares — EVP & President, North America
    2026-05-15INSIDERStraus Robert D transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERYang Rong transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERKopf Curtis transacted 4.5k sh Common Shares — Director
    2026-05-15INSIDERRoering Tess transacted 4.5k sh Common Shares — Director
    2026-05-11FILING8-K filing →
    2026-05-07FILING8-K filing →
    Showing the 40 most recent of 54 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage